USA - NASDAQ:INVE - US45170X2053 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to INVE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-08-08 | B. Riley Securities | Maintains | Buy -> Buy | 
| 2025-05-08 | Lake Street | Maintains | Buy -> Buy | 
| 2025-03-06 | Lake Street | Maintains | Buy -> Buy | 
| 2024-08-09 | B. Riley Securities | Maintains | Buy -> Buy | 
| 2024-08-09 | Craig-Hallum | Maintains | Buy -> Buy | 
| 2024-05-09 | Craig-Hallum | Maintains | Buy -> Buy | 
| 2024-03-13 | B. Riley Securities | Maintains | Buy -> Buy | 
| 2023-06-26 | B. Riley Securities | Upgrade | Neutral -> Buy | 
| 2022-11-03 | B. Riley Securities | Downgrade | Buy -> Neutral | 
| 2022-11-03 | Northland Capital Markets | Downgrade | Outperform -> Market Perform | 
| 2022-10-04 | B. Riley Securities | Maintains | Buy | 
| 2022-06-15 | B. Riley Securities | Maintains | Buy | 
| 2022-04-25 | Craig-Hallum | Initiate | Buy | 
| 2022-04-14 | B. Riley Securities | Maintains | Buy | 
| 2021-04-13 | B. Riley FBR | Initiate | Buy | 
9 analysts have analysed INVE and the average price target is 5.44 USD. This implies a price increase of 39.49% is expected in the next year compared to the current price of 3.9.
The consensus rating for IDENTIV INC (INVE) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering IDENTIV INC (INVE) is 9.